journal
https://read.qxmd.com/read/38127081/bilateral-acute-iris-transillumination-after-systemic-moxifloxacin-treatment
#81
JOURNAL ARTICLE
Hannah W Ng
No abstract text is available yet for this article.
December 1, 2023: JAMA Ophthalmology
https://read.qxmd.com/read/38127080/iris-neovascularization-after-vitreous-metastasis-of-a-cutaneous-melanoma
#82
JOURNAL ARTICLE
Gaia Leone, Marco Nassisi, Francesco Viola
No abstract text is available yet for this article.
December 1, 2023: JAMA Ophthalmology
https://read.qxmd.com/read/37971726/social-determinants-of-health-and-perceived-barriers-to-care-in-diabetic-retinopathy-screening
#83
MULTICENTER STUDY
Rohith Ravindranath, Isaac A Bernstein, Karen S Fernandez, Cassie A Ludwig, Sophia Y Wang
IMPORTANCE: Regular screening for diabetic retinopathy often is crucial for the health of patients with diabetes. However, many factors may be barriers to regular screening and associated with disparities in screening rates. OBJECTIVE: To evaluate the associations between visiting an eye care practitioner for diabetic retinopathy screening and factors related to overall health and social determinants of health, including socioeconomic status and health care access and utilization...
December 1, 2023: JAMA Ophthalmology
https://read.qxmd.com/read/37943569/large-language-model-advanced-data-analysis-abuse-to-create-a-fake-data-set-in-medical-research
#84
JOURNAL ARTICLE
Andrea Taloni, Vincenzo Scorcia, Giuseppe Giannaccare
No abstract text is available yet for this article.
December 1, 2023: JAMA Ophthalmology
https://read.qxmd.com/read/37943564/risk-of-new-retinal-vascular-occlusion-after-messenger-rna-covid-19-vaccination-within-aggregated-electronic-health-record-data
#85
LETTER
Ying-Cheng Chen, Chin-Cheng Chen, James Cheng-Chung Wei
No abstract text is available yet for this article.
December 1, 2023: JAMA Ophthalmology
https://read.qxmd.com/read/37943549/do-not-think-of-a-purple-wolf-keratoconus-adhd-and-itch
#86
JOURNAL ARTICLE
Maria A Woodward, Emily L Vogt
No abstract text is available yet for this article.
December 1, 2023: JAMA Ophthalmology
https://read.qxmd.com/read/37943546/risk-of-new-retinal-vascular-occlusion-after-messenger-rna-covid-19-vaccination-within-aggregated-electronic-health-record-data
#87
LETTER
Po-Jui Chu, Ting-Han Tai, Tzu-Hsuan Fan
No abstract text is available yet for this article.
December 1, 2023: JAMA Ophthalmology
https://read.qxmd.com/read/37943544/risk-of-new-retinal-vascular-occlusion-after-messenger-rna-covid-19-vaccination-within-aggregated-electronic-health-record-data-reply
#88
LETTER
Jacqueline K Shaia, Priya Shukla, Rishi P Singh
No abstract text is available yet for this article.
December 1, 2023: JAMA Ophthalmology
https://read.qxmd.com/read/37943541/intraocular-pressure-in-eyes-with-retinal-vein-occlusion-compared-with-fellow-eyes-study-of-comparative-treatments-for-retinal-vein-occlusion-2-score2-report-27
#89
COMPARATIVE STUDY
Ahmad A Aref, Ingrid U Scott, Neal L Oden, Michael S Ip, Paul C VanVeldhuisen, Barbara A Blodi
No abstract text is available yet for this article.
December 1, 2023: JAMA Ophthalmology
https://read.qxmd.com/read/37943540/psychiatric-comorbidities-associated-with-keratoconus
#90
COMMENT
Margarita Safir, Idan Hecht, Dan Heller, Eran Pras, Michal Lifshitz, Adi Einan-Lifshitz
IMPORTANCE: Evaluating risk factors for keratoconus, often associated with recurrent eye rubbing, could generate hypotheses to be tested in future interventional trials. OBJECTIVE: To assess the risk for keratoconus associated with psychiatric comorbidities in adolescents and adults. DESIGN, SETTING, AND PARTICIPANTS: This population-based cross-sectional study included medical records of Israeli adolescents and adults in military service from January 2011 through December 2021...
December 1, 2023: JAMA Ophthalmology
https://read.qxmd.com/read/37943534/risk-of-new-retinal-vascular-occlusion-after-messenger-rna-covid-19-vaccination-within-aggregated-electronic-health-record-data
#91
LETTER
Alan Y Hsu, Chun-Ju Lin, James Cheng-Chung Wei
No abstract text is available yet for this article.
December 1, 2023: JAMA Ophthalmology
https://read.qxmd.com/read/37917077/pathogen-surveillance-for-acute-infectious-conjunctivitis
#92
JOURNAL ARTICLE
Edmund Tsui, Ruti Sella, Vivien Tham, Alan W Kong, Esmeralda McClean, Lee Goren, Irit Bahar, Nina Cherian, Joana Ramirez, Reginald E Hughes, Joseph K Privratsky, Tania Onclinx, Rachel Feit-Leichman, Angel Cheng, Iliana Molina, Phillip Kim, Carol Yu, Kevin Ruder, Alexander Tan, Cindi Chen, YuHeng Liu, Thomas Abraham, Armin Hinterwirth, Lina Zhong, Travis C Porco, Thomas M Lietman, Gerami D Seitzman, Thuy Doan
IMPORTANCE: Acute infectious conjunctivitis is a common ocular condition with major public health consequences. OBJECTIVE: To assess regional variations and microbial etiologies of acute infectious conjunctivitis to guide treatment. DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional study, patients with presumed acute infectious conjunctivitis were enrolled in the study at 5 sites (Honolulu, Hawaii; Los Angeles, San Francisco, and San Diego, California; and Petah-Tikva, Israel) from March 2021 to March 2023...
December 1, 2023: JAMA Ophthalmology
https://read.qxmd.com/read/37917076/fever-and-neutropenia-can-be-a-risk-to-the-child-s-life
#93
JOURNAL ARTICLE
Ann M Leahey, Carol L Shields
No abstract text is available yet for this article.
December 1, 2023: JAMA Ophthalmology
https://read.qxmd.com/read/37917073/incidence-and-risk-factors-for-neutropenia-after-intra-arterial-chemotherapy-for-retinoblastoma
#94
COMMENT
Debora H Lee, Richard Donkor, Matthew N Parvus, Mark J Dannenbaum, Amy C Schefler
IMPORTANCE: Intra-arterial chemotherapy (IAC) has quickly gained popularity as a mainstay of treatment for retinoblastoma. Intra-arterial chemotherapy has been described as having several advantages over systemic chemotherapy, including reducing systemic toxicity and neutropenia; however, studies on the risk of neutropenia after IAC remain limited. OBJECTIVE: To estimate the incidence of neutropenia after IAC, as well as identify risk factors associated with the development of neutropenia...
December 1, 2023: JAMA Ophthalmology
https://read.qxmd.com/read/37883115/machine-learning-models-for-predicting-long-term-visual-acuity-in-highly-myopic-eyes
#95
JOURNAL ARTICLE
Yining Wang, Ran Du, Shiqi Xie, Changyu Chen, Hongshuang Lu, Jianping Xiong, Daniel S W Ting, Kengo Uramoto, Koju Kamoi, Kyoko Ohno-Matsui
IMPORTANCE: High myopia is a global concern due to its escalating prevalence and the potential risk of severe visual impairment caused by pathologic myopia. Using artificial intelligence to estimate future visual acuity (VA) could help clinicians to identify and monitor patients with a high risk of vision reduction in advance. OBJECTIVE: To develop machine learning models to predict VA at 3 and 5 years in patients with high myopia. DESIGN, SETTING, AND PARTICIPANTS: This retrospective, single-center, cohort study was performed on patients whose best-corrected VA (BCVA) at 3 and 5 years was known...
December 1, 2023: JAMA Ophthalmology
https://read.qxmd.com/read/37883068/risk-of-stroke-myocardial-infarction-and-death-after-retinal-artery-occlusion
#96
JOURNAL ARTICLE
Karen M Wai, Austen Knapp, Cassie A Ludwig, Euna Koo, Ravi Parikh, Ehsan Rahimy, Prithvi Mruthyunjaya
IMPORTANCE: Patients with retinal artery occlusions (RAOs) are recommended to have emergent stroke workup, although the true risk of death and subsequent vascular events post-RAO is not clear. OBJECTIVE: To determine short-term and long-term rates of stroke, myocardial infarction (MI), and death in patients after RAO compared with a control cohort. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used aggregated electronic health records from January 1, 2003, through April 14, 2023, from TriNetX, a network with data from more than 111 million patients...
December 1, 2023: JAMA Ophthalmology
https://read.qxmd.com/read/37991790/rising-incidence-of-syphilitic-uveitis-related-hospitalizations-in-the-us
#97
JOURNAL ARTICLE
Tahreem A Mir, Stephen J Kim, Wei Fang, Justin Harvey, David M Hinkle
IMPORTANCE: The number of syphilis cases continues to increase in the US every year since 2001 with a 74% increase observed since 2017. In addition, there remains a national shortage of injectable penicillin G. Despite the increase in reported cases, to the authors' knowledge, there has been no recent nationwide study investigating the trends in incidence of syphilitic uveitis. OBJECTIVE: To evaluate the national and regional incidence of syphilitic uveitis-related hospitalizations in the US...
November 22, 2023: JAMA Ophthalmology
https://read.qxmd.com/read/37991754/genetic-counseling-for-predictive-retinal-imaging
#98
JOURNAL ARTICLE
Samantha R De Silva, Omar A Mahroo, Peter Charbel Issa
No abstract text is available yet for this article.
November 22, 2023: JAMA Ophthalmology
https://read.qxmd.com/read/37971736/surgical-approach-and-reoperation-risk-in-intermittent-exotropia-in-the-iris-registry
#99
JOURNAL ARTICLE
Isdin Oke, Tobias Elze, Joan W Miller, Alice C Lorch, David G Hunter
IMPORTANCE: There is no consensus on the optimal surgical treatment for children with intermittent exotropia (IXT). OBJECTIVE: To compare the 5-year reoperation rates for children with IXT treated with horizontal muscle strabismus surgery using bilateral lateral rectus recession (BLR) vs unilateral lateral rectus recession with medial rectus resection (RR). DESIGN, SETTING, AND PARTICIPANTS: This cohort study examined data obtained from the Intelligent Research in Sight (IRIS) Registry on 7482 children (age, <18 years) with IXT who underwent horizontal eye muscle strabismus surgery between January 1, 2013, and December 31, 2017...
November 16, 2023: JAMA Ophthalmology
https://read.qxmd.com/read/37971723/efficacy-and-safety-of-brolucizumab-for-diabetic-macular-edema-the-kingfisher-randomized-clinical-trial
#100
JOURNAL ARTICLE
Rishi P Singh, Mark R Barakat, Michael S Ip, Charles C Wykoff, David A Eichenbaum, Sunir Joshi, David Warrow, Veeral S Sheth, Jana Stefanickova, Yong Soo Kim, Fanyin He, Ga Eun Cho, Yuhua Wang, Andrés Emanuelli
IMPORTANCE: Despite the effectiveness of existing anti-vascular endothelial growth factor (VEGF) therapies, a need remains for further treatment options to improve response rates and/or reduce injection or monitoring frequency in patients with diabetic macular edema (DME). OBJECTIVE: To evaluate the efficacy and safety of brolucizumab vs aflibercept dosed every 4 weeks in participants with DME. DESIGN, PARTICIPANTS, AND SETTING: This 52-week, double-masked, phase 3 randomized clinical trial included treatment-naive adults and adults who had previously received anti-VEGF therapy...
November 16, 2023: JAMA Ophthalmology
journal
journal
44130
5
6
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.